Life Sciences / Biotech
The intellectual property lawyers and technical specialists of the Life Sciences/Biotech Practice Group use their legal, biotechnology and life sciences skills to evaluate current technologies and provide expert advice on intellectual property strategy and business development. They have years of experience in the pharmaceutical industry, technology transfer and licensing, life sciences patents and conducting intellectual property audits and due diligence studies. In addition to providing a full range of Life Sciences patent services, our clients look to us for licensing their technology or developing internal intellectual property policies and procedures.
The practice group includes patent attorneys and technical advisors who have years of experience and expertise in biotechnology, bioinformatics, immunology, agricultural biotechnology, gene therapy, genomics, medical devices, diagnostics, pharmaceuticals, proteomics, vaccines and drug delivery.
Many of our group members hold doctorate or advanced scientific degrees in immunology, biochemistry, botany, biotechnology and molecular biology. Many have worked as examiners at the United States Patent and Trademark Office (USPTO) or have held various positions in industry as researchers or in-house counsel.
We understand the complex USPTO procedures, as well as the scientific and business issues. This is what makes the difference for you. BSKB provides uniquely insightful technical advice and intellectual property legal counsel to a growing list of clients who enjoy the benefits of that added value.
Attorneys and Professionals
Related Articles
-
September 20, 2024
’Hear my story’ – Giving voice to first-generation lawyers and clerks
WIPR
At BSKB, we are committed to fostering an inclusive legal community. Our latest article by Dr. MaryAnne Armstrong, "’Hear my story’ – Giving voice to first-generation lawyers and clerks" highlights the unique challenges and strengths of new attorneys and law clerks from first-generation and limited-income (FGLI) backgrounds.
-
December 26, 2022
Key U.S. Supreme Court Developments in 2022 and Outlook for 2023
IPWatchdog
As the 2022 year comes to an end, Dr. Hailey Bureau reflects on the Intellectual Property industry and the key SCOTUS decisions of 2022 that impacted patent and trademark law.
Related Presentations
-
November 20, 2024
The Appeal Review Panel and Ex parte Chamberlain
-
October 23, 2024
Resolution of Arthrex Decision and DOC New Rules
-
October 9, 2024
Recent Developments in Obviousness-Type Double Patenting
-
September 25, 2024
Overview of USPTO’s July 2024 guidance on patent subject matter eligibility concerning AI-related inventions
Related News
-
November 7, 2024
Birch, Stewart, Kolasch & Birch, LLP Ranked by Best Law Firms® in 2025
BSKB has been recognized in the 2025 edition of Best Law Firms® ranking for Patent Law; Biotechnology and Life Sciences Practice; and Litigation – Intellectual Property.
-
October 7, 2024
USPTO Announcement
On September 25, 2024, the U.S. Patent and Trademark Office (USPTO) issued a Notice that a recent update to their software introduced a coding error into the patent term adjustment (PTA) software used to perform PTA determinations.